tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

IRON Stock Latest News

Disc Medicine assumed with an Overweight at Morgan Stanley
The FlyDisc Medicine assumed with an Overweight at Morgan Stanley
2h ago
IRON
Disc Medicine’s Promising Future: Buy Rating Backed by Strong Pipeline and Growth Potential
PremiumRatings
Disc Medicine’s Promising Future: Buy Rating Backed by Strong Pipeline and Growth Potential
3h ago
IRON
Promising Potential of Bitopertin in Treating Erythropoietic Protoporphyria Drives Buy Rating for Disc Medicine
PremiumRatings
Promising Potential of Bitopertin in Treating Erythropoietic Protoporphyria Drives Buy Rating for Disc Medicine
4h ago
IRON
Disc Medicine’s Promising Hematology Pipeline and Positive Trial Results Earn Buy Rating
PremiumRatings
Disc Medicine’s Promising Hematology Pipeline and Positive Trial Results Earn Buy Rating
14d ago
IRON
Top Analysts Pound the Table on These Three Stocks, 6/18/2025
PremiumMarket News
Top Analysts Pound the Table on These Three Stocks, 6/18/2025
15d ago
ELV
IRON
Promising Potential of Disc Medicine’s Bitopertin Drives Buy Rating
PremiumRatingsPromising Potential of Disc Medicine’s Bitopertin Drives Buy Rating
16d ago
IRON
Disc Medicine’s Promising Clinical Pipeline and Strong Financial Position Justify Buy Rating
Premium
Ratings
Disc Medicine’s Promising Clinical Pipeline and Strong Financial Position Justify Buy Rating
17d ago
IRON
Disc Medicine Holds 2025 Annual Stockholders Meeting
Premium
Company Announcements
Disc Medicine Holds 2025 Annual Stockholders Meeting
20d ago
8K
IRON
Promising Developments in Disc Medicine’s Portfolio Support Buy Rating
PremiumRatings
Promising Developments in Disc Medicine’s Portfolio Support Buy Rating
20d ago
IRON
Disc Medicine presents clinical data updates across portfolio at EHA 2025
PremiumThe Fly
Disc Medicine presents clinical data updates across portfolio at EHA 2025
21d ago
IRON
Disc Medicine resumed with a Strong Buy at Raymond James
PremiumThe Fly
Disc Medicine resumed with a Strong Buy at Raymond James
23d ago
IRON
Disc Medicine’s Promising Potential in Myelofibrosis Anemia Treatment: Analyst Highlights Unique Mechanism and Market Opportunity
PremiumRatings
Disc Medicine’s Promising Potential in Myelofibrosis Anemia Treatment: Analyst Highlights Unique Mechanism and Market Opportunity
2M ago
IRON
Disc Medicine price target raised to $120 from $112 at BMO Capital
PremiumThe FlyDisc Medicine price target raised to $120 from $112 at BMO Capital
2M ago
IRON
Disc Medicine’s Promising Position in MF Anemia Treatment: Buy Rating Affirmed by Evan Seigerman
Premium
Ratings
Disc Medicine’s Promising Position in MF Anemia Treatment: Buy Rating Affirmed by Evan Seigerman
2M ago
IRON
Promising Outlook for Disc Medicine’s DISC-0974 in Anemia Treatment Justifies Buy Rating
Premium
Ratings
Promising Outlook for Disc Medicine’s DISC-0974 in Anemia Treatment Justifies Buy Rating
2M ago
IRON
Disc Medicine Reports Strong Q1 2025 Progress
PremiumCompany Announcements
Disc Medicine Reports Strong Q1 2025 Progress
2M ago
IRON
Buy Rating for Disc Medicine Driven by Promising Bitopertin Prospects and Strategic Advancements
PremiumRatings
Buy Rating for Disc Medicine Driven by Promising Bitopertin Prospects and Strategic Advancements
2M ago
IRON
Promising Developments at Disc Medicine: NDA Filing and Phase III Trial for Bitopertin in EPP
PremiumRatings
Promising Developments at Disc Medicine: NDA Filing and Phase III Trial for Bitopertin in EPP
2M ago
IRON
Disc Medicine’s Strong Financial Health and Promising Clinical Pipeline Justify Buy Rating
PremiumRatings
Disc Medicine’s Strong Financial Health and Promising Clinical Pipeline Justify Buy Rating
2M ago
IRON
Disc Medicine reports Q1 EPS ($1.02), consensus ($1.07)
PremiumThe FlyDisc Medicine reports Q1 EPS ($1.02), consensus ($1.07)
2M ago
IRON
Iron Planet Inc. trading resumes
Premium
The Fly
Iron Planet Inc. trading resumes
3M ago
IRON
Iron Planet Inc. trading halted, volatility trading pause
Premium
The Fly
Iron Planet Inc. trading halted, volatility trading pause
3M ago
IRON

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >